Edition:
United States

Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

106.50EUR
11:35am EDT
Change (% chg)

€-1.25 (-1.16%)
Prev Close
€107.75
Open
€107.55
Day's High
€107.90
Day's Low
€106.45
Volume
418,745
Avg. Vol
411,695
52-wk High
€115.20
52-wk Low
€82.00

Latest Key Developments (Source: Significant Developments)

Merck and CLEARink Displays sign development agreement
Tuesday, 10 Jan 2017 04:20am EST 

Merck Kgaa :Signs a comprehensive materials development agreement with CLEARink Displays, Inc., aiming to bring CLEARink's innovative and patented reflective display technology to market by end of 2017.  Full Article

Advanced Nano Technologies signs revised supply agreement with Merck KGaA
Thursday, 22 Dec 2016 12:53am EST 

Advanced Nano Technologies Ltd : expects as a result of agreement that it will positively impact on profitability of co in fy17 & fy18 . Terms of revised agreement remain confidential .Reached agreement with merck kgaa to revise terms of its existing supply arrangements for alusion.  Full Article

Roche expands distribution alliance with life science business
Thursday, 1 Dec 2016 08:00am EST 

Merck Kgaa :Roche expands distribution alliance with life science business of Merck kgaa, darmstadt, Germany to include kapa biosystems qpcr and endpoint pcr portfolios.  Full Article

Transgene announces collaboration with Merck KGaA, Darmstadt, Germany and Pfizer to evaluate the combination of TG4001 with Avelumab
Tuesday, 11 Oct 2016 11:47am EDT 

Transgene : Transgene announces collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to evaluate the combination of TG4001 with Avelumab in HPV-positive head & neck cancer in a phase 1/2 study . Transgene- this is an exclusive agreement between parties to study combination of these two classes of investigational agents in HPV-positive HNSCC .Transgene- phase I trial is expected to begin in France, with first patient expected to be recruited in H1 2017.  Full Article

Merck KGaA announces Isabel de Paoli new chief strategy officer
Friday, 23 Sep 2016 10:03am EDT 

Merck KGaA :Today announced that Isabel de Paoli has been appointed chief strategy officer effective Oct. 1, 2016.  Full Article

Moody's changes outlook on Merck KGAA's ratings to stable from negative; affirms ratings
Tuesday, 30 Aug 2016 12:20pm EDT 

: Moody's changes outlook on Merck KGAA's ratings to stable from negative; affirms ratings . Moody's on Merck KGAA -Outlook change prompted by solid operating performance since assigning negative outlook in Dec 2014 due to Sigma-Aldrich deal . Moody's on Merck KGAA -Pace of deleveraging has been slightly behind expectations largely owing to delayed closing of the Sigma-Aldrich acquisition Source -http://bit.ly/2bXHwy2 ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Merck KGaA says fertility unit benefiting from production problems at 2 U.S. rivals
Thursday, 4 Aug 2016 04:48am EDT 

Merck KGaA media call : CEO on fertility business, benefiting from 2 competing products in U.S. held back by production problems . CEO says unclear how long positive effect will last because production of one rival fertility product has resumed . CEO says will file for first avelumab approval in U.S. at end-Q3, in Europe towards year-end . CEO says currently have no active plans to divest any businesses, though constantly reviewing our portfolio . CFO says acquisitions worth more than 500 million eur not on the agenda for next 2 years Further company coverage: [MRCG.DE] ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;)).  Full Article

Germany's Merck KGaA, AmoyDx collaborate to bring liquid biopsy RAS biomarker testing to China
Thursday, 28 Jul 2016 02:46am EDT 

Merck KGaA : Merck and Amoy Diagnostics Co Ltd collaborate to bring liquid biopsy RAS biomarker testing to China . Merck and AmoyDx plan to implement ADx-SuperARMS liquid biopsy RAS test in Chinese medical centers in 2017​ .Merck and AmoyDx ‍plan to expand into other markets such as Argentina, India, Mexico, Taiwan, Hong Kong, Brazil, Russia by 2019​.  Full Article

India's Merck Ltd June-qtr profit up about 6 pct
Monday, 25 Jul 2016 06:24am EDT 

Merck Ltd : India's Merck Ltd - June-quarter net profit 179 million rupees; net sales 2.53 billion rupees . Net profit in June-quarter last year was 168.6 million rupees; net sales was 2.41 billion rupees .  Full Article

Merck says EMA accepts cladribine for review marketing authorisation application
Monday, 18 Jul 2016 02:00am EDT 

Merck Kgaa :EMA has accepted for review marketing authorization application (MAA) of investigational product cladribine tablets for treatment of relapsing-remitting multiple sclerosis.  Full Article

More From Around the Web

Photo

Merck KGaA TV crystals sales decline raises stakes for cancer drug

FRANKFURT Merck KGaA's sales of liquid crystals used in flat-screen TVs are now expected to decline this year, making the German company more reliant on its new cancer immunotherapy drug to fuel growth.